HIGHLIGHTS
- who: Hung-Hsuan Yen from the Department of Surgery, National Taiwan University Hospital, No, have published the research: Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience, in the Journal: (JOURNAL)
- what: This study showed the comparable outcomes of 5-year RFS and OS for patients with pathological stage II-IIIB (excluding T1 cases; AJCC 8th) gastric cancer receiving adjuvant UFT or S-1 monotherapy following D2 gastrectomy by the same surgical team.
- future: Emerging evidences also indicated that a longer duration of S-1 adjuvant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.